ITGA2B and Glanzmann thrombasthenia 1: Current research suggests that gain‐of‐function mutations in ITGA2B or ITGB3 underlie the pathogenesis of most ITGA2B/ITGB3‐related macrothrombocytopenia and mechanistically distinguish it from classical GT.